Xueqing Yu

712 total citations
17 papers, 513 citations indexed

About

Xueqing Yu is a scholar working on Nephrology, Rheumatology and Surgery. According to data from OpenAlex, Xueqing Yu has authored 17 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 6 papers in Rheumatology and 4 papers in Surgery. Recurrent topics in Xueqing Yu's work include Gout, Hyperuricemia, Uric Acid (9 papers), Systemic Lupus Erythematosus Research (4 papers) and Alcohol Consumption and Health Effects (3 papers). Xueqing Yu is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (9 papers), Systemic Lupus Erythematosus Research (4 papers) and Alcohol Consumption and Health Effects (3 papers). Xueqing Yu collaborates with scholars based in China, United States and Australia. Xueqing Yu's co-authors include Fengxian Huang, Xi Xia, Guangji Wang, Shu‐Feng Zhou, Charlie Changli Xue, Zhenchuan Lin, Qimei Luo, Bin Li, Richard J. Johnson and Haiping Mao and has published in prestigious journals such as American Journal of Kidney Diseases, Metabolism and BMJ Open.

In The Last Decade

Xueqing Yu

16 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xueqing Yu China	10	347	147	129	106	77	17	513
Z. Tsutsumi Japan	14	340 1.0×	112 0.8×	164 1.3×	164 1.5×	78 1.0×	29	597
Yasuhiro Takano Japan	8	198 0.6×	117 0.8×	153 1.2×	83 0.8×	55 0.7×	32	453
Yulin Li China	12	459 1.3×	182 1.2×	168 1.3×	219 2.1×	86 1.1×	21	724
Ana Carolina Moron Gagliardi Brazil	10	203 0.6×	255 1.7×	128 1.0×	104 1.0×	42 0.5×	10	616
Chun‐Cheng Hou Taiwan	12	316 0.9×	101 0.7×	300 2.3×	40 0.4×	20 0.3×	19	699
Zhao Hu China	14	146 0.4×	45 0.3×	106 0.8×	110 1.0×	40 0.5×	46	508
Athanasios Roumeliotis Greece	14	293 0.8×	102 0.7×	66 0.5×	50 0.5×	16 0.2×	41	572
Αnila Duni Greece	12	216 0.6×	91 0.6×	125 1.0×	50 0.5×	20 0.3×	31	632
Letian Yang China	13	173 0.5×	76 0.5×	185 1.4×	50 0.5×	16 0.2×	33	535
Yanhuan Feng China	12	158 0.5×	75 0.5×	168 1.3×	50 0.5×	16 0.2×	28	463

Countries citing papers authored by Xueqing Yu

Since Specialization

Citations

This map shows the geographic impact of Xueqing Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueqing Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueqing Yu more than expected).

Fields of papers citing papers by Xueqing Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueqing Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueqing Yu. The network helps show where Xueqing Yu may publish in the future.

Co-authorship network of co-authors of Xueqing Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xueqing Yu. A scholar is included among the top collaborators of Xueqing Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueqing Yu. Xueqing Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wen, Qiong, Xueqing Tang, Qian Zhou, Wei Chen, & Xueqing Yu. (2022). Clinicopathological Patterns and Outcomes in Patients with Lupus Nephritis and Hyperuricemia. Journal of Clinical Medicine. 11(11). 3075–3075. 3 indexed citations

Rong, Rong, Qiong Wen, Yating Wang, et al.. (2021). Prognostic significance of hypertension at the onset of lupus nephritis in Chinese patients: prevalence and clinical outcomes. Journal of Human Hypertension. 36(2). 153–162. 5 indexed citations

Huang, Naya, Huiyan Li, Li Fan, et al.. (2021). Serum Phosphorus and Albumin in Patients Undergoing Peritoneal Dialysis: Interaction and Association With Mortality. Frontiers in Medicine. 8. 760394–760394. 11 indexed citations

Chen, Wei, Naya Huang, Haiping Mao, et al.. (2020). Rationale and design for Lowering-hyperUricaemia treatment on cardiovascular outcoMes In peritoNeal diAlysis patients: a prospective, multicentre, double-blind, randomised controlled trial (LUMINA). BMJ Open. 10(10). e037842–e037842. 1 indexed citations

Luo, Qimei, Xi Xia, Bin Li, et al.. (2019). Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis. BMC Nephrology. 20(1). 18–18. 42 indexed citations

Liu, Xinhui, Juan Wu, Haishan Wu, et al.. (2018). Association of Serum Uric Acid with Arterial Stiffness in Peritoneal Dialysis Patients. Kidney & Blood Pressure Research. 43(5). 1451–1458. 3 indexed citations

Chen, Dongni, Li Fan, Yuxi Wu, et al.. (2018). A Predictive Model for Estimation Risk of Proliferative Lupus Nephritis. Chinese Medical Journal. 131(11). 1275–1281. 15 indexed citations

Xia, Xi, Qimei Luo, Bin Li, et al.. (2016). Serum uric acid and mortality in chronic kidney disease: A systematic review and meta-analysis. Metabolism. 65(9). 1326–1341. 81 indexed citations

Zhang, Wang, Lingyao Hong, Qian Zhou, et al.. (2015). Clinical Outcomes of Lupus Nephritis Patients with Different Proportions of Crescents. Hong Kong Journal of Nephrology. 17(2). S52–S52.

10.

Xia, Xi, Feng He, Xianfeng Wu, et al.. (2013). Relationship Between Serum Uric Acid and All-Cause and Cardiovascular Mortality in Patients Treated With Peritoneal Dialysis. American Journal of Kidney Diseases. 64(2). 257–264. 64 indexed citations

11.

Yan, Lei, et al.. (2013). Sulodexide may alleviate neointimal hyperplasia by inhibiting angiopoietin-2 in an arteriovenous fistula model. Molecular Medicine Reports. 7(3). 831–835. 4 indexed citations

12.

Li, Zhibin, Qinghua Liu, Haiping Mao, et al.. (2012). Gender Difference in the Association of Hyperuricemia with Chronic Kidney Disease in Southern China. Kidney & Blood Pressure Research. 36(1). 98–106. 11 indexed citations

13.

Aparicio, Michel, Vincenzo Bellizzi, Philippe Chauveau, et al.. (2012). Keto Acid Therapy in Predialysis Chronic Kidney Disease Patients: Final Consensus. Journal of Renal Nutrition. 22(2). S22–S24. 42 indexed citations

14.

Wei, Xin, Ricong Xu, Zhenhua Yang, et al.. (2012). Novel Uromodulin Mutation in Familial Juvenile Hyperuricemic Nephropathy. American Journal of Nephrology. 36(2). 114–120. 15 indexed citations

15.

Shi, Yongjun, Wei Chen, Diana Jalal, et al.. (2011). Clinical Outcome of Hyperuricemia in IgA Nephropathy: A Retrospective Cohort Study and Randomized Controlled Trial. Kidney & Blood Pressure Research. 35(3). 153–160. 113 indexed citations

16.

Zhou, Shu‐Feng, Charlie Changli Xue, Xueqing Yu, & Guangji Wang. (2007). Metabolic Activation of Herbal and Dietary Constituents and Its Clinical and Toxicological Implications: An Update. Current Drug Metabolism. 8(6). 526–553. 99 indexed citations

17.

Zhang, Yajie, Xiao Yang, Yunfang Zhang, et al.. (2006). Effect of 15d--PGJ_(2) on the expression of CD40 and RANTES induced by IFN--gamma and TNF--alpha on renal tubular epithelial cells （HK--2）. Zhongguo mianyixue zazhi. 22(10). 889–894. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact